{"article": [{"url": "https://www.marketwatch.com/story/moderna-inc-stock-rises-wednesday-still-underperforms-market-01602102330", "published": 1602088400.0, "headline": "Moderna Inc. stock rises Wednesday, still underperforms market", "body": "Shares of Moderna Inc. MRNA, +0.09% advanced 1.87% to $72.37 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP, +1.39% rising 1.88% to 11,364.60 and the Dow Jones Industrial Average DJIA, +0.56% rising 1.91% to 28,303.46. Moderna Inc. closed $22.84 below its 52-week high ($95.21), which the company achieved on July 17th. The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as AbbVie Inc. ABBV, +0.41% rose 1.37% to $87.07 and Amgen Inc. AMGN, -1.41% rose 1.97% to $257.67. Trading volume (4.2 M) remained 7.4 million below its 50-day average volume of 11.5 M. Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use."}]}